Eton Pharmaceuticals (ETON) Accumulated Depreciation & Amortization (2019 - 2024)
Historic Accumulated Depreciation & Amortization for Eton Pharmaceuticals (ETON) over the last 6 years, with Q4 2024 value amounting to $446000.0.
- Eton Pharmaceuticals' Accumulated Depreciation & Amortization rose 1291.14% to $446000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $446000.0, marking a year-over-year increase of 1291.14%. This contributed to the annual value of $446000.0 for FY2024, which is 1291.14% up from last year.
- Latest data reveals that Eton Pharmaceuticals reported Accumulated Depreciation & Amortization of $446000.0 as of Q4 2024, which was up 1291.14% from $434000.0 recorded in Q3 2024.
- Eton Pharmaceuticals' Accumulated Depreciation & Amortization's 5-year high stood at $605000.0 during Q3 2020, with a 5-year trough of $14000.0 in Q3 2022.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $370000.0 (2023), whereas its average is $276950.0.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first plummeted by 9603.31% in 2021, then skyrocketed by 263571.43% in 2023.
- Quarter analysis of 5 years shows Eton Pharmaceuticals' Accumulated Depreciation & Amortization stood at $347000.0 in 2020, then tumbled by 55.33% to $155000.0 in 2021, then tumbled by 57.42% to $66000.0 in 2022, then skyrocketed by 498.48% to $395000.0 in 2023, then increased by 12.91% to $446000.0 in 2024.
- Its Accumulated Depreciation & Amortization was $446000.0 in Q4 2024, compared to $434000.0 in Q3 2024 and $422000.0 in Q2 2024.